Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on: September 27,2024 0

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on:September 27,2024 0

Scientists map the evolution of urinary tract cancer cells

by Weill Cornell Medical CollegeImaging Mass Cytometry shows the immune-inflamed subtype of upper tract urothelial carcinoma at single-cell resolution. Red: tumor-expressed E-cadherin; Green: T-c

Updated on: March 30,2024 0

Scientists map the evolution of urinary tract cancer cells

by Weill Cornell Medical CollegeImaging Mass Cytometry shows the immune-inflamed subtype of upper tract urothelial carcinoma at single-cell resolution. Red: tumor-expressed E-cadherin; Green: T-c

Updated on:March 30,2024 0

New tools used to identify childhood cancer genes

by UT Southwestern Medical CenterEmbryonal rhabdomyosarcoma cells. Credit: UT SouthwesternUsing a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 gene

Updated on: May 09,2024 5

New tools used to identify childhood cancer genes

by UT Southwestern Medical CenterEmbryonal rhabdomyosarcoma cells. Credit: UT SouthwesternUsing a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 gene

Updated on:May 09,2024 5

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on: January 22,2024 18

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on:January 22,2024 18

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Updated on: April 07,2024 11

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Updated on:April 07,2024 11

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on: July 17,2024 0

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on:July 17,2024 0

Molecular culprit behind virus-mediated chronic inflammation and cancers identified

by Public Library of ScienceBC-3 cells were stained with DAPI, anti-vFLIP, anti-CADM1, and cholera toxin B conjugated with red fluorescence to detect GM-1 and subjected to confocal microscopy. Cr

Updated on: March 01,2024 12

Molecular culprit behind virus-mediated chronic inflammation and cancers identified

by Public Library of ScienceBC-3 cells were stained with DAPI, anti-vFLIP, anti-CADM1, and cholera toxin B conjugated with red fluorescence to detect GM-1 and subjected to confocal microscopy. Cr

Updated on:March 01,2024 12

App an effective tool to record sun exposure

by Queensland University of TechnologyCredit: Queensland University of TechnologyA smartphone app is an accessible tool that reliably measures the amount of exposure to the sun's skin-damagin

Updated on: March 30,2024 14

App an effective tool to record sun exposure

by Queensland University of TechnologyCredit: Queensland University of TechnologyA smartphone app is an accessible tool that reliably measures the amount of exposure to the sun's skin-damagin

Updated on:March 30,2024 14

Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta

Updated on: February 23,2024 14

Researchers find a potential therapeutic target to prevent dissemination of cancer cells in the central nervous system

by Instituto de Medicina MolecularGraphical abstract. Credit:Neuro-Oncology Advances(2023). DOI: 10.1093/noajnl/vdad048A new study led by Cláudia C. Faria, researcher in the lab of João Ta

Updated on:February 23,2024 14

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca

Updated on: August 28,2024 0

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca

Updated on:August 28,2024 0

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on: August 28,2024 0

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on:August 28,2024 0

Study of immune 'neighborhoods' highlights macrophages as key players in invasive breast cancers

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainMost immunotherapies, which aim to boost T cell activity, work poorly in treating estrogen receptor-positive (ER+) breast cancer. Targ

Updated on: January 02,2024 9

Study of immune 'neighborhoods' highlights macrophages as key players in invasive breast cancers

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainMost immunotherapies, which aim to boost T cell activity, work poorly in treating estrogen receptor-positive (ER+) breast cancer. Targ

Updated on:January 02,2024 9